Form 4: GeneDx Holdings CFO Kevin Feeley Executes Stock Transactions Following RSU Vesting
SEC Form 4 Filing
GeneDx Holdings CFO Kevin Feeley sold 275 shares of Class A Common Stock to cover tax obligations after the vesting of 753 Restricted Stock Units (RSUs).
Summary
- Kevin Feeley, the Chief Financial Officer of GeneDx Holdings Corp., engaged in transactions involving the company's Class A Common Stock on January 29, 2025.
- 753 Restricted Stock Units (RSUs) vested, each representing a contingent right to receive one share of Class A Common Stock.
- Following the vesting, 275 shares were sold at a weighted average price of $78.4804 per share to cover tax withholding obligations.
- The sales occurred in multiple transactions with prices ranging from $78.48 to $78.5983 per share.
- After these transactions, Mr. Feeley directly owns 2,950 shares of Class A Common Stock and 3,767 RSUs.
Sentiment
Score: 6
Explanation: The document reflects standard executive stock transactions related to RSU vesting, which is neither particularly positive nor negative. The sentiment is neutral.
Positives
- The vesting of RSUs indicates that performance milestones were likely met.
- The sale of shares to cover tax obligations is a standard practice for RSU vesting.
Risks
- The sale of shares by an executive could be perceived negatively by some investors, although it is a common practice for tax obligations.
- Fluctuations in the stock price could impact the value of the remaining shares and RSUs held by Mr. Feeley.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.
Comparison to Industry Standards
- The sale of shares to cover tax obligations upon RSU vesting is a standard practice across publicly traded companies.
- Many companies use a 'sell-to-cover' mechanism to handle tax liabilities associated with equity compensation.
- The price range of $78.48 to $78.5983 per share is within the expected range for a company of this type, assuming the stock price is stable.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they are related to executive compensation and tax obligations.
- The sale of shares may slightly increase the supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 01/29/2025 | Date of RSU vesting and stock sale transactions. |
| 01/31/2025 | Date of SEC Form 4 filing. |
Keywords
GeneDx Holdings, Kevin Feeley, Restricted Stock Units, RSU, Class A Common Stock, SEC Form 4, Insider Trading, Stock Sale, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.